Federal regulators on Monday granted full approval to the Pfizer-BioNTech coronavirus vaccine — a milestone that could help increase inoculation rates and spark a wave of vaccine mandates by employers and universities amid a surge of new cases and hospitalizations fueled by the ferocious delta variant.
Share
Comment
Save
The Washington Post is providing this news free to all readers as a public service.
Follow this story and more by signing up for national breaking news email alerts.